treosulfan (Grafapex)
Jump to navigation
Jump to search
Indications
- in combination with fludarabine in preparation for allogeneic hematopoietic stem cell transplantation in patients with cute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)
Adverse effects
- most common
- musculoskeletal pain, stomatitis, pyrexia, nausea, edema, infection, vomiting.
- laboratory abnormalities
- increased serum GGT, serum bilirubin, serum ALT, serum AST, serum creatinine
Mechanism of action
More general terms
References
- ↑ Bassett M FDA Approves Treosulfan as part of AML/MDS Conditioning Regimen. Drug is approved in combination with fludarabine.